UBS Asset Management Americas Inc. increased its position in shares of Amdocs Limited (NASDAQ:DOX) by 0.2% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 395,146 shares of the technology company’s stock after buying an additional 648 shares during the period. UBS Asset Management Americas Inc.’s holdings in Amdocs Limited were worth $24,100,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Creative Planning boosted its stake in shares of Amdocs Limited by 62.7% in the first quarter. Creative Planning now owns 2,198 shares of the technology company’s stock worth $134,000 after buying an additional 847 shares during the last quarter. ProShare Advisors LLC acquired a new stake in shares of Amdocs Limited during the first quarter worth $224,000. Wetherby Asset Management Inc. boosted its stake in shares of Amdocs Limited by 4.4% in the first quarter. Wetherby Asset Management Inc. now owns 3,812 shares of the technology company’s stock worth $232,000 after buying an additional 162 shares during the last quarter. Sciencast Management LP acquired a new stake in shares of Amdocs Limited during the fourth quarter worth $286,000. Finally, Genesee Valley Trust Co. acquired a new stake in shares of Amdocs Limited during the first quarter worth $298,000. Institutional investors and hedge funds own 91.03% of the company’s stock.

Institutional Ownership by Quarter for Amdocs Limited (NASDAQ:DOX)

Shares of Amdocs Limited (DOX) opened at 64.75 on Friday. The company’s 50-day moving average is $63.82 and its 200-day moving average is $61.03. Amdocs Limited has a one year low of $54.12 and a one year high of $66.48. The company has a market capitalization of $9.48 billion, a PE ratio of 23.47 and a beta of 0.54.

Amdocs Limited (NASDAQ:DOX) last posted its quarterly earnings results on Tuesday, May 9th. The technology company reported $0.88 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.87 by $0.01. The business had revenue of $966 million during the quarter, compared to the consensus estimate of $960.58 million. Amdocs Limited had a net margin of 10.84% and a return on equity of 14.46%. Amdocs Limited’s revenue for the quarter was up 4.3% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.92 earnings per share. Equities analysts predict that Amdocs Limited will post $3.79 earnings per share for the current year.

The firm also recently declared a quarterly dividend, which will be paid on Friday, July 14th. Investors of record on Friday, June 30th will be paid a dividend of $0.22 per share. This represents a $0.88 dividend on an annualized basis and a dividend yield of 1.36%. The ex-dividend date is Wednesday, June 28th. Amdocs Limited’s dividend payout ratio (DPR) is 31.88%.

COPYRIGHT VIOLATION NOTICE: This piece of content was first reported by Watch List News and is owned by of Watch List News. If you are reading this piece of content on another publication, it was stolen and reposted in violation of US and international trademark and copyright legislation. The correct version of this piece of content can be viewed at https://www.watchlistnews.com/ubs-asset-management-americas-inc-has-24-10-million-position-in-amdocs-limited-dox/1371998.html.

A number of brokerages recently weighed in on DOX. Jefferies Group LLC restated a “hold” rating and set a $59.00 target price on shares of Amdocs Limited in a report on Friday. Robert W. Baird raised their target price on shares of Amdocs Limited from $62.00 to $66.00 and gave the stock a “neutral” rating in a report on Wednesday, May 10th. BidaskClub cut shares of Amdocs Limited from a “hold” rating to a “sell” rating in a report on Tuesday, June 13th. Zacks Investment Research upgraded shares of Amdocs Limited from a “hold” rating to a “buy” rating and set a $72.00 target price for the company in a report on Monday, May 22nd. Finally, J P Morgan Chase & Co restated a “neutral” rating and set a $68.00 target price on shares of Amdocs Limited in a report on Tuesday, May 9th. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating and three have assigned a buy rating to the stock. The company has an average rating of “Hold” and an average price target of $66.29.

About Amdocs Limited

Amdocs Limited is a provider of software and services for communications, entertainment and media industry service providers. The Company develops, implements and manages software and services associated with business support systems (BSS), operational support systems (OSS) and network operations to enable service providers to introduce new products and services, process orders, monetize data, support new business models and enhance their understanding of their customers.

Want to see what other hedge funds are holding DOX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amdocs Limited (NASDAQ:DOX).

Receive News & Ratings for Amdocs Limited Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs Limited and related companies with Analyst Ratings Network's FREE daily email newsletter.